Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alto Neuroscience Inc ANRO

Healthcare
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. Through insights derived from the Company’s scalable and proprietary Precision Psychiatry Platform, which applies rigorous data science and robust analytics to data gathered by... see more

Recent & Breaking News (NYSE:ANRO)

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alto Neuroscience, Inc. (ANRO) And Encourages Stockholders to Reach Out

Accesswire November 1, 2024

Investors Who Lost Money on Alto Neuroscience, Inc. Should Contact Levi & Korsinsky about an Ongoing Investigation - ANRO

Accesswire November 1, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alto Neuroscience, Inc. (ANRO) And Encourages Stockholders to Connect

Accesswire October 31, 2024

Shareholder Rights Advocates at Levi & Korsinsky Investigate Alto Neuroscience, Inc. (ANRO) Regarding Possible Securities Fraud Violations

Accesswire October 30, 2024

Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Investors With Losses Are Encouraged To Contact The Schall Law Firm

Accesswire October 30, 2024

ATTENTION ANRO SHAREHOLDERS: Investors who lost money on Alto Neuroscience, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

Accesswire October 30, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alto Neuroscience, Inc. (ANRO) And Encourages Shareholders to Reach Out

Accesswire October 30, 2024

Alto Neuroscience, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - ANRO

Accesswire October 29, 2024

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire October 29, 2024

ANRO ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you Lost Money on your Alto Neuroscience, Inc. Investment

Accesswire October 29, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alto Neuroscience, Inc. (ANRO) and Encourages Investors to Learn More About the Investigation

Accesswire October 29, 2024

Alto Neuroscience, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - ANRO

Accesswire October 28, 2024

Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Encouraged To Contact The Schall Law Firm

Accesswire October 28, 2024

Lost Money on Alto Neuroscience, Inc. (ANRO)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

Accesswire October 28, 2024

Alto Neuroscience, Inc. (ANRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Accesswire October 28, 2024

Alto Neuroscience, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Alto Neuroscience, Inc. (ANRO)

Accesswire October 28, 2024

ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Alto Neuroscience, Inc. and Encourages Investors to Contact the Firm

Business Wire October 27, 2024

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Accesswire October 27, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alto Neuroscience, Inc. (ANRO) And Encourages Stockholders to Reach Out

Accesswire October 27, 2024

Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Encouraged To Help The Schall Law Firm

Accesswire October 26, 2024